NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cuorips Inc. Logo
Develops iPS cell-derived therapies and provides cell processing contract services.
Japan
4894
Cuprina Holdings (Cayman) LTD Logo
Biomedical firm developing wound care biotherapy and cosmeceutical products.
United States of America
CUPR
Curanex Pharmaceuticals Inc Logo
Develops botanical drugs for inflammatory diseases like ulcerative colitis.
United States of America
CURX
Curasight A/S Logo
A clinical-stage biotech developing a theranostic platform for cancer diagnosis and treatment.
Denmark
CURAS
Curevac Logo
A biopharmaceutical company developing therapies based on messenger RNA (mRNA) technology.
Germany
CVAC
CureVac N.V. Logo
A biopharmaceutical company developing mRNA-based medicines for a range of diseases.
United States of America
CVAC
CURIS INC Logo
Biotechnology company developing and commercializing therapeutics for cancer treatment.
United States of America
CRIS
Curocell Inc. Logo
A clinical-stage biotech developing CAR-T therapies for blood cancers.
South Korea
372320
CYBIN INC. Logo
A late-stage neuropsychiatry company developing psychedelic-based therapeutics.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Develops personalized biofeedback therapies for treatment-resistant depression.
United States of America
CYCN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.